This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción LXG.H
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de LexaGene Holdings Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.10 |
| 52 Week High | CA$0.30 |
| 52 Week Low | CA$0.065 |
| Beta | 2.25 |
| 1 Month Change | 0% |
| 3 Month Change | -19.23% |
| 1 Year Change | -43.24% |
| 3 Year Change | -87.20% |
| 5 Year Change | -91.60% |
| Change since IPO | -58.00% |
Noticias y actualizaciones recientes
Recent updates
It's Unlikely That LexaGene Holdings Inc.'s (CVE:LXG) CEO Will See A Huge Pay Rise This Year
Feb 02
We're A Little Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Rate
Oct 07Here's Why We're Not Too Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Situation
May 17We Think LexaGene Holdings (CVE:LXG) Can Afford To Drive Business Growth
Feb 01Rentabilidad de los accionistas
| LXG.H | CA Medical Equipment | Mercado CA | |
|---|---|---|---|
| 7D | 0% | -2.9% | -2.1% |
| 1Y | -43.2% | -27.9% | 3.6% |
Rentabilidad vs. Industria: LXG.H underperformed the Canadian Medical Equipment industry which returned -1% over the past year.
Rentabilidad vs. Mercado: LXG.H underperformed the Canadian Market which returned -2.4% over the past year.
Volatilidad de los precios
| LXG.H volatility | |
|---|---|
| LXG.H Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 11.6% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Precio estable de las acciones: LXG.H's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine LXG.H's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2007 | 33 | Jack Regan | www.lexagene.com |
Resumen de fundamentos de LexaGene Holdings Inc.
| Estadísticas fundamentales de LXG.H | |
|---|---|
| Capitalización bursátil | CA$14.78m |
| Beneficios(TTM) | -CA$11.53m |
| Ingresos (TTM) | CA$140.83k |
104.9x
Ratio precio-ventas (PS)-1.3x
Ratio precio-beneficio (PE)¿Está LXG.H sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de LXG.H | |
|---|---|
| Ingresos | US$104.27k |
| Coste de los ingresos | US$757.46k |
| Beneficio bruto | -US$653.19k |
| Otros gastos | US$7.89m |
| Beneficios | -US$8.54m |
Últimos beneficios comunicados
Nov 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.061 |
| Margen bruto | -626.46% |
| Margen de beneficio neto | -8,189.91% |
| Ratio deuda/patrimonio | 66.4% |
¿Cómo se ha desempeñado LXG.H a largo plazo?
Ver rendimiento histórico y comparativa